Schedule 13D ownership disclosure

MEI Pharma, Inc.

Common Stock, $0.00000002 par value · CUSIP: 55279B202

Event date: 2025-07-22

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Funicular Funds, LPReported CIK 0001937147

    Shares: 35,300.00 · Class: 0.1%

  • Cable Car Capital, LPReported CIK 0001699575

    Shares: 35,300.00 · Class: 0.1%

  • Ma-Weaver JacobReported CIK 0001922140

    Shares: 35,300.00 · Class: 0.1%

  • Anson Investments Master Fund LPReported CIK 0001504872

    Shares: 841,674.00 · Class: 2.8%

  • AIMF GP LLC

    Shares: 841,674.00 · Class: 2.8%

  • Anson East Master Fund LP

    Shares: 214,304.00 · Class: 0.7%

  • AEMF GP LLC

    Shares: 214,304.00 · Class: 0.7%

  • Anson Opportunities Master Fund LP

    Shares: 37,210.00 · Class: 0.1%

  • AOMF GP, LLC

    Shares: 37,210.00 · Class: 0.1%

  • Anson Funds Management LPReported CIK 0001491072

    Shares: 1,093,188.00 · Class: 3.7%

  • Anson Management GP LLCReported CIK 0001491073

    Shares: 1,093,188.00 · Class: 3.7%

  • Tony MooreReported CIK 0002012586

    Shares: 1,093,188.00 · Class: 3.7%

  • Anson Advisors Inc.Reported CIK 0001581079

    Shares: 1,093,188.00 · Class: 3.7%

  • Amin NathooReported CIK 0001962354

    Shares: 1,093,188.00 · Class: 3.7%

  • Moez KassamReported CIK 0001585167

    Shares: 1,093,188.00 · Class: 3.7%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000921895-25-002023
Form type
SCHEDULE 13D/A
Filer
Anson Funds Management LP
CIK
CIK 1491072
Filed
Jul 24, 2025
Reporting period
Jul 22, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub